Instituto Valenciano de Oncología (IVO)
- Address
- Carrer de Professor Beltrán Báguena, 8, 46009 Valencia, Spain
Low‑Grade Upper Tract Urothelial Cancer
The Instituto Valenciano de Oncología (IVO) urology service is evaluating a novel organ‑preserving approach for low‑grade upper tract urothelial cancer using a targeted light‑based therapy. The trial aims to confirm safety, efficacy, and long‑term durability of the treatment.
- Efficacy assessment of the photodynamic procedure
- Durability of tumor response over time
- Organ‑preserving outcomes for kidney and ureter
- Comprehensive safety monitoring
This study showcases the site’s focus on innovative vascular targeted photodynamic therapy to improve outcomes for patients with urothelial tumors.
Metastatic Colorectal Cancer
In the same department, a trial is testing a new immunotherapy agent for metastatic colorectal cancer, seeking to extend overall survival compared with the current standard regimen. Researchers are comparing the single‑agent and combination use of Precemtabart Tocentecan with or without bevacizumab.
- Evaluation of single‑agent activity
- Combination therapy with bevacizumab
- Direct comparison to Trifluridine/Tipiracil plus Bevacizumab
- Analysis of survival benefit and quality of life
The investigation reflects the centre’s commitment to advancing treatment options for advanced colorectal disease.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Merck Healthcare KGaA1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 567 other sites in Spain
Therapeutic Area Benchmark — Spain
Select a therapeutic area to compare against other sites in Spain.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Spain
Market Share
Country: Spain
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Instituto Valenciano de Oncología (IVO)
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Padeliporfin Vascular Targeted Photodynamic Therapy in Low-Grade Upper Tract Urothelial Carcinoma: A Phase 3 Multicenter Study | Steba Biotech S.A. | Phase III | Not Recruiting | Oct 2022 | — |
IMP list
lock Showing 1 of 4 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Bevacizumab | 1 | Unknown | — | — |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.